Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

Ganglion Resection Effectiveness Trial

Study ID: NCT07162415
Start Date: 2025-11
End Date: 2035-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

220

Intervention / Treatment

Open resection

Arthroscopic resection

Conservative treatment

Sponsor

Tampere University Hospital

Source: clinicaltrials.gov

Share:
Add to list

Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial

Study ID: NCT06923397
Start Date: 2025-10
End Date: 2026-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Interrupted Sedentary Time Intervention

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

Study ID: NCT06821997
Start Date: 2025-10-01
End Date: 2027-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Fluorouracil

Irinotecan Sucrosofate

Leucovorin calcium

Oxaliplatin

Surgical Procedure

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

Study ID: NCT05199688
Start Date: 2025-09-30
End Date: 2029-09-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

8

Intervention / Treatment

Session

Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list

Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer

Study ID: NCT06774027
Start Date: 2025-10-15
End Date: 2030-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Specimen collection

Non-Investigational Antibody-Drug Conjugates (ADC)

Medical Record Review

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.

Study ID: NCT05776927
Start Date: 2026-02-01
End Date: 2029-02-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

304

Intervention / Treatment

QVM149

Salmeterol Xinafoate / Fluticasone Propionate

Placebo to QVM149

Placebo to Salmeterol Xinafoate / Fluticasone Propionate

Run-In Medication

Rescue Medication

Concept 1 Device

Girohaler

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease

Study ID: NCT06878131
Start Date: 2025-09-30
End Date: 2028-12-22
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Colorectal Cancer

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene

Study ID: NCT06052631
Start Date: 2025-10-01
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

16

Intervention / Treatment
Sponsor

National Center for Complementary and Integrative Health (NCCIH)

Source: clinicaltrials.gov

Share:
Add to list

Co-Creating Active Middle School Communities to Increase Student Physical Activity

Study ID: NCT06970067
Start Date: 2026-01-05
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

450

Intervention / Treatment

Active Middle School Communities

Sponsor

Deanna Hoelscher

Source: clinicaltrials.gov

Share:
Add to list

Evaluate the Effect of Vimseltinib on Organic Cation Transporter 2 (OCT2)

Study ID: NCT07158411
Start Date: 2025-11
End Date: 2026-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Vimely

Metformin

Sponsor

Deciphera Pharmaceuticals, LLC

Source: clinicaltrials.gov

Share:
Add to list